The Advertised Price Is Not the Price: Membership Fees, Dose Tiers and Prepay Traps

Published: 2026-08-03 · Last reviewed: 2026-08-04 · Methodology v4.1 · Journal
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · journal · corrections.

An advertised GLP-1 price is frequently the medication at a starting dose, on a prepaid annual plan, excluding a membership fee. Four structures create the gap between that number and your card statement, and all four are visible if you ask four questions.

The four structures

How an advertised figure becomes a different number
StructureHow it worksWhat it adds
Membership separate from medicationA monthly platform fee outside the drug price$50–$100/month, permanently
Dose-tiered pricingPrice rises as you titrate30–60% by maintenance
Introductory rateFirst month or two onlyReverts, often sharply
Prepay-only pricingThe headline needs 6 or 12 months upfront$1,700–$2,400 committed

These stack. A price can be an introductory, prepaid, starting-dose figure with a membership on top.

Advertised against actual, at a maintenance dose
Advertised headline$99Plus membership$178Plus dose tier at maintenance$278Flat-rate alternative, all in$145Approved tablet, maintenance$299

Illustrative of the stacking pattern, using figures in this market's typical range. Flat-rate structures do not move with dose.

Why the dose tier matters most. Every published efficacy figure was collected at a maintenance dose. A price quoted at a starting dose is a price for a dose no trial measured an outcome at. So the advertised figure and the evidence describe different points in treatment, and comparing across providers on that figure compares the wrong number.

The four questions

  1. What is the all-in monthly total at a maintenance dose, including every fee?
  2. Is there a membership or platform fee separate from the medication?
  3. Does the price change as the dose increases? If so, to what, at each step?
  4. What is refundable if I stop in month two?

A provider with flat pricing and no membership answers all four in a sentence. One with three of the four structures usually answers in a paragraph that does not contain a number.

What a flat structure actually means

"Flat at every dose" is a genuine differentiator, and it is worth checking rather than accepting: ask which doses the flat rate covers, in milligrams. A flat rate that stops below the maintenance dose is a dose tier with better marketing.

Reading a pricing page properly

What each phrase usually means
Phrase on the pageWhat it usually means
"Starting at"The lowest dose, on the longest prepay term
"From $X/month"Same, and the figure may exclude membership
"As low as"The best case for someone who is not you
"Membership included"Check whether medication is
"No hidden fees"Ask what the maintenance-dose total is anyway
"Flat pricing"Ask which doses in mg the flat rate covers

None of these is dishonest on its face. All of them describe a best case.

Common questions

Why is the first month so much cheaper?

Two reasons that look identical on a pricing page: an explicit introductory rate, or a dose tier where month one is a starting dose. The first reverts on a date; the second rises as your dose does. Ask which one you are looking at, because they behave differently.

Is a membership fee ever worth it?

It can be, if it buys something you need: clinician access, insurance advocacy, structured follow-up. What makes it a problem is not the fee but its exclusion from the headline figure, which prevents a like-for-like comparison.

How do I compare providers fairly?

One number: the all-in monthly total at a maintenance dose, on the shortest term you would actually commit to. Every provider can answer it, and the answer collapses all four structures into a single comparable figure.

Working an example end to end

Take a headline of $99 a month and follow it to the card statement. Each step below is a structure that exists in this market, and they compound.

  1. $99 — the advertised figure, quoted at the 0.25 mg starting dose.
  2. + $79 membership — a separate platform fee, disclosed at checkout rather than on the pricing page. Running total $178.
  3. + dose tier — by the maintenance dose the medication component has risen. Running total around $278.
  4. Prepay condition — the $99 required twelve months upfront, so the commitment was about $2,136 made before dose one.

Nothing in that sequence is hidden in the sense of concealed. All of it is disclosed somewhere. What it is not is comparable to a flat all-in figure from another provider, which is the only thing a buyer is trying to do.

The same year, three structures
StructureMonth 1At maintenanceTwelve months
Headline + membership + dose tier$178$278~$3,000
Flat, all-in, monthly$165$165$1,980
Flat, all-in, 12-month prepay$145$145$1,740
Approved oral tablet$149$299$3,588

The provider advertising $99 is not the cheapest at twelve months. It is the cheapest for one month at a dose no trial measured an outcome at.

Why this pattern persists

Because comparison sites rank on the advertised figure. A provider that quotes an all-in maintenance price ranks below one that quotes a starting dose, even when it is genuinely cheaper over a year. The structure is a response to how the market is ranked, and it will persist while that ranking does.

The defence is individual and simple: ask every provider the same single question — the all-in monthly total at a maintenance dose — and compare only those numbers.

Twelve-month total, four structures
Flat all-in, 12-month prepay$1,740Flat all-in, monthly$1,980Headline + membership + dose tier$3,000Approved tablet, maintenance$3,588Brand pen, self-pay$4,188

The provider advertising the lowest monthly figure is not the cheapest over a year.

What this page does not settle

The single defensible comparison in this market is the all-in monthly total at a maintenance dose. Every other number is a best case for someone.

One more structure worth naming

Shipping and supplies. Syringes, alcohol swabs and sharps disposal are inexpensive individually and are sometimes billed separately, sometimes bundled, and occasionally not supplied at all — which leaves a patient with a vial and no way to draw from it. Expedited shipping is frequently an add-on, and cold-chain handling can be too.

None of this is large money against a $2,000 year. It matters because it is the category of cost most often left out of a comparison entirely, and because discovering it at checkout after committing to a twelve-month prepay is the wrong moment. Add it to the four questions: what arrives in the box, and what does shipping cost?

Not medical advice. This page reports what published trials and manufacturers state. It is not a diagnosis, a dosing instruction or a recommendation for any individual. Every efficacy figure here was collected on an FDA-approved product; no compounded preparation has a trial of its own. Talk to a licensed clinician before starting, changing or stopping any medication.